To investigate whether a fixed-dose combination ( FDC ) of 0.5 mg dutasteride and 0.4 mg tamsulosin is more effective than watchful waiting with protocol-defined initiation of tamsulosin therapy if symptoms did not improve ( WW-All ) in treatment-nave men with moderately symptomatic benign prostatic hyperplasia ( BPH ) at risk of progression .